The Leaky Gut: A New Frontier in Coeliac Disease and Systemic Health
A comprehensive review in *Gut* explores the central role of increased intestinal permeability in the pathophysiology of coeliac disease. The article details the mechanisms behind this “leaky gut,” including the involvement of zonulin, inflammatory cytokines, and immune responses to gliadin peptides. It also provides a thorough analysis of emerging therapies aimed at restoring barrier integrity, from specific diets and supplements to investigational drugs like larazotide acetate and IMU-856. The authors advocate for further research into these barrier-normalizing strategies as a potential method for maintaining remission in patients with chronic kidney disease and other systemic conditions linked to intestinal permeability.
Study Significance: For nephrology professionals, this research underscores the systemic implications of gut-barrier dysfunction, a concept increasingly relevant to chronic kidney disease progression and uremia. Understanding these mechanisms could inform novel adjunctive strategies for managing CKD, particularly in patients with comorbid autoimmune or inflammatory conditions. It highlights a shift toward investigating extra-renal therapeutic targets to modulate systemic inflammation and potentially slow renal function decline.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
This article sheds light on how the concept of leaky gut might expand our understanding of Coeliac Disease beyond just digestive symptoms. It’s interesting to think about how gut permeability could influence other systemic issues like autoimmune reactions or chronic inflammation.